February 18, 2022 02:07 PM ESTUpdated 04:28 PM
Pharma
Coronavirus
Manufacturing

Pub­lic Cit­i­zen ac­cus­es Pfiz­er of build­ing 'patent wal­l' for Covid treat­ment, set­ting up in­equities again

Josh Sullivan

Pub­lic Cit­i­zen has called out Pfiz­er. Again.

The con­sumer ad­vo­ca­cy non­prof­it is­sued a state­ment Fri­day claim­ing the Big Phar­ma is build­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times